You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vandetanib

Showing 101 - 118 of 118
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial in Los Angeles (Weekly Abraxane and Daily Vandetanib, Abraxane every three weeks and daily vandetanib)

Completed
  • Solid Tumors
  • Weekly Abraxane and Daily Vandetanib
  • Abraxane every three weeks and daily vandetanib
  • Los Angeles, California
    University of Southern California (U.S.C.)/ Norris Comprehensive
Nov 18, 2014

Solid Tumor Trial (temozolomide, vandetanib, immunoenzyme technique)

Withdrawn
  • Unspecified Adult Solid Tumor, Protocol Specific
  • (no location specified)
Mar 6, 2014

Advanced Incurable Solid Malignancy Trial in Pittsburgh (Vandetanib, Gemcitabine, Oxaliplatin)

Completed
  • Advanced Incurable Solid Malignancy
  • Vandetanib
  • +2 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute / Hillman Cancer Cente
Jan 21, 2014

Metastatic Breast Cancer Trial in Boston (Vandetanib, Cyclophosphamide, Methotrexate)

Completed
  • Metastatic Breast Cancer
  • Vandetanib
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 14, 2013

Malignant Gliomas Trial in Aurora (Vandetanib, Fractionated Stereotactic Radiotherapy)

Completed
  • Malignant Gliomas
  • Vandetanib
  • Fractionated Stereotactic Radiotherapy
  • Aurora, Colorado
    University of Colorado Health Science Center
Jun 24, 2013

Metastatic Breast Cancer Trial in Canada (Fulvestrant + ZACTIMA, Fulvestrant + Placebo)

Completed
  • Metastatic Breast Cancer
  • Fulvestrant + ZACTIMA
  • Fulvestrant + Placebo
  • Edmonton, Alberta, Canada
  • +12 more
Nov 15, 2013

Gliosarcoma, Glioblastoma Trial in Durham (Vandetanib and Etoposide)

Completed
  • Gliosarcoma
  • Glioblastoma
  • Vandetanib and Etoposide
  • Durham, North Carolina
    Duke University Health System
Feb 19, 2013

Prostate Cancer Trial in Canada (Vandetanib, Bicalutamide)

Completed
  • Prostate Cancer
  • Kelowna, British Columbia, Canada
  • +3 more
Feb 19, 2013

Brain and CNS Tumors Trial in Memphis (vandetanib)

Completed
  • Brain and Central Nervous System Tumors
  • vandetanib
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 11, 2012

Glioblastoma, Gliosarcoma Trial in Durham (Zactima, Gleevec, Hydroxyurea)

Completed
  • Glioblastoma
  • Gliosarcoma
  • Zactima, Gleevec, Hydroxyurea
  • Durham, North Carolina
    Duke University Health System
Dec 4, 2012

Anal, Colon, and Rectal Cancers, Colorectal Tumors, Colon/Rectal Cancer Trial in Stanford (Vandetanib, Capecitabine,

Completed
  • Anal, Colon, and Rectal Cancers
  • +2 more
  • Vandetanib
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Jul 12, 2012

Ovarian Tumors, Fallopian Tube Tumors, Peritoneal Tumors Trial run by the NCI (Vandetanib)

Terminated
Has Results
  • Ovarian Neoplasms
  • +2 more
  • Vandetanib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
May 22, 2012

Pancreatic Cancer Trial in United Kingdom (Placebo, Caprelsa (vandetanib))

Unknown status
  • Pancreatic Cancer
  • Placebo
  • Caprelsa (vandetanib)
  • Belfast, United Kingdom
  • +13 more
May 16, 2012

Lung Cancer, Lymphoma, Lymphoproliferative Disorder Trial run by the CC (biological, drug, other)

Completed
  • Lung Cancer
  • +4 more
  • bevacizumab
  • +3 more
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Trials Refe
Mar 14, 2012

Lung Cancer Trial in Charleston (BIBW 2992 (Afatinib))

Withdrawn
  • Lung Cancer
  • BIBW 2992 (Afatinib)
  • Charleston, South Carolina
    Medical University of South Carolina
Mar 25, 2013

Neuroblastoma Trial in Houston (ZD6474, Retinoic Acid)

Terminated
  • Neuroblastoma
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Dec 13, 2011

Colorectal Cancer Trial in Boston (ZD6474, Cetuximab, Irinotecan)

Completed
  • Colorectal Cancer
  • Boston, Massachusetts
  • +2 more
Oct 3, 2012

Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer Trial in Cleveland (docetaxel, oxaliplatin, vandetanib)

Terminated
  • Adenocarcinoma of the Gastroesophageal Junction
  • Esophageal Cancer
  • Cleveland, Ohio
    Case Medical Center, University Hospitals Seidman Cancer Center,
Aug 19, 2011